Key Market Segments:
By Product
-
- Standard Pen Needles
- Safety Pen Needles
By Needle Length
-
- 4mm
- 5mm
- 6mm
- 8mm
- 10mm
- 12mm
By Therapy
-
- Insulin
- Glucagon-like-peptide-1
- Growth Hormone
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online channels
By End-Use
- Hospitals and clinics
- Home care settings
- Other end-users
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
- US
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Poland
- Turkey
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Australia
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g., Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated the Pen Needles Market in 2024.
BD (Becton, Dickinson and Company), Novo Nordisk A/S, Terumo Corporation, Owen Mumford Ltd., Ypsomed Holding AG, Allison Medical, Inc., HTL-Strefa S.A. (a MTD Group company), Artsana S.p.A. (Pic Solution), Arkray, Inc., UltiMed, Inc., and other players.
Advancements in needle technology are propelling the market growth.
The Pen Needles Market is expected to grow at a CAGR of 10.26%.
The Pen Needles Market was valued at USD 3.42 billion in 2024 and is expected to reach USD 7.43 billion by 2032.